These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 6142494
1. Tardive dyskinesia and the primary psychiatric diagnosis. Yassa R, Nair V, Schwartz G. Psychosomatics; 1984 Feb; 25(2):135-8. PubMed ID: 6142494 [No Abstract] [Full Text] [Related]
2. Risk factors for tardive dyskinesia according to primary psychiatric diagnosis. Wolf ME, DeWolfe AS, Mosnaim AD. Hillside J Clin Psychiatry; 1987 Feb; 9(1):3-11. PubMed ID: 2888712 [Abstract] [Full Text] [Related]
3. The clinical association of tardive dyskinesia and drug-induced parkinsonism. Wolf ME, Chevesich J, Lehrer E, Mosnaim AD. Biol Psychiatry; 1983 Oct; 18(10):1181-8. PubMed ID: 6140032 [No Abstract] [Full Text] [Related]
5. Tardive dyskinesia in patients receiving lithium maintenance therapy. Perényi A, Szücs R, Frecska E. Biol Psychiatry; 1984 Nov; 19(11):1573-8. PubMed ID: 6151403 [No Abstract] [Full Text] [Related]
6. Prevalence of dystonia in veterans on chronic antipsychotic therapy. Sethi KD, Hess DC, Harp RJ. Mov Disord; 1990 Nov; 5(4):319-21. PubMed ID: 1979658 [Abstract] [Full Text] [Related]
7. Follow-up study on the reversibility of tardive dyskinesia. Wegner JT, Kane JM. Am J Psychiatry; 1982 Mar; 139(3):368-9. PubMed ID: 6120658 [No Abstract] [Full Text] [Related]
8. Palliative treatment of tardive dyskinesia with combination of amantadine-neuroleptic administration. Allen RM. Biol Psychiatry; 1982 Jun; 17(6):719-27. PubMed ID: 6179548 [Abstract] [Full Text] [Related]
9. The impact of olanzapine on tardive dyskinetic symptoms in a state hospital population. Brar JS, Parepally H, Chalasani L, Gopalani A, Appel N, Chengappa KN. Ann Clin Psychiatry; 2008 Jun; 20(3):139-44. PubMed ID: 18633740 [Abstract] [Full Text] [Related]
10. [Utility of quetiapine in tardive dyskinesia]. Navarro Pacheco BV, Montejo González AL, Martín Carrasco M. Actas Esp Psiquiatr; 2003 Jun; 31(6):347-52. PubMed ID: 14639511 [Abstract] [Full Text] [Related]
11. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence. Kane JM. J Clin Psychiatry; 2004 Jun; 65 Suppl 9():16-20. PubMed ID: 15189107 [Abstract] [Full Text] [Related]
13. The prevalence of tardive dyskinesia. Kane JM, Woerner M, Lieberman JA, Weinhold P, Florio W, Rubinstein M, Rotrosen J, Kurucz J, Mukherjee S, Bergmann K. Psychopharmacol Bull; 1985 Jan; 21(1):136-9. PubMed ID: 2858906 [No Abstract] [Full Text] [Related]
14. [Psychopathology and cognitive disorders in chronic schizophrenic patients with tardive dyskinesia]. Kaiser W. Nervenarzt; 1989 Apr; 60(4):206-12. PubMed ID: 2566936 [No Abstract] [Full Text] [Related]
15. Tardive dyskinesia syndrome in neuroleptic therapy. General considerations and clinical observations on forty cases investigated. Chiriţă V, Boişteanu P, Pirozynski T. Rev Med Chir Soc Med Nat Iasi; 1987 Apr; 91(1):53-64. PubMed ID: 2889249 [No Abstract] [Full Text] [Related]
16. Drugs for psychiatric disorders. Med Lett Drugs Ther; 1991 May 17; 33(844):43-50. PubMed ID: 1674103 [No Abstract] [Full Text] [Related]
17. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics. Glazer WM. J Clin Psychiatry; 2000 May 17; 61 Suppl 4():15-20. PubMed ID: 10739326 [Abstract] [Full Text] [Related]
18. Informing patients about tardive dyskinesia: four-year follow up of a trial of patient education. Chaplin R, Timehin C. Aust N Z J Psychiatry; 2002 Feb 17; 36(1):99-103. PubMed ID: 11929445 [Abstract] [Full Text] [Related]
20. [First results of symptom statistical studies on the characterization of the clinical effect profile of the antidepressive agent noxiptilin]. Bente D, Engelmeier MP, Heinrich K, Hippius H, Schmitt W. Arzneimittelforschung; 1969 Jun 17; 19():Suppl 5a:889+. PubMed ID: 5819770 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]